Hongchao Wang

Title: Innovations of Hongchao Wang in Psoriasis Treatment

Introduction

Hongchao Wang is a notable inventor based in Wuxi, China. He has made significant contributions to the field of microbial and medical technologies. His work focuses on innovative solutions for health-related issues, particularly in the treatment of psoriasis.

Latest Patents

Hongchao Wang holds a patent for "Bifidobacterium brevis and its application in preventing or alleviating psoriasis thereof." This patent discloses a strain capable of preventing and relieving psoriasis. The invention provides new uses of CCFM1078 in inhibiting the release of IL-23/Th17 axis related inflammatory factors, which are crucial in the pathology of psoriasis. The CCFM1078 strain has shown promising results in relieving the lesion skin of psoriasis-like mice. It can inhibit the thickening of the skin epidermal layer, leading to a decrease in IL-23, IL-22, and IL-17 levels in the skin by 20.3%, 22.0%, and 18.3%, respectively. This innovation has great application prospects in the preparation of products aimed at preventing and treating psoriasis.

Career Highlights

Hongchao Wang is affiliated with Jiangnan University, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on health and wellness.

Collaborations

He collaborates with notable colleagues, including Gang Wang and Wenwei Lu, to further enhance the research and development of microbial technologies.

Conclusion

Hongchao Wang's innovative work in the field of psoriasis treatment exemplifies the potential of microbial technologies in medical applications. His contributions are paving the way for new therapeutic options for individuals suffering from this condition.